» Articles » PMID: 31685789

Long Noncoding RNA VIM Antisense RNA 1 (VIM-AS1) Plays an Important Role in Development of Preeclampsia by Regulation of Epithelial Mesenchymal Transition

Overview
Journal Med Sci Monit
Date 2019 Nov 6
PMID 31685789
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Long noncoding RNAs play important roles in the development of various diseases. This study aimed to evaluate the effects and mechanism of VIM antisense RNA 1 (VIM-AS1) in the development of preeclampsia. MATERIAL AND METHODS HTR-8/SVneo cells were divided into normal control (NC), Model, Blank, and VIM-AS1 groups. These groups were analyzed for their VIM-AS1 gene expressions by RT-PCR, HTR-8/SVneo cell invasion was assessed by transwell and migration by wound healing, cell morphology was assessed by microscopy examination, and E-cadherin, Snail, and Vimentin genes expressions were assessed by RT-PCR and WB assay. RESULTS VIM-AS1 gene expression was significantly different among normal placenta tissue, mild preeclampsia tissues, and severe preeclampsia tissues (P<0.001 or P<0.01). VIM-AS1 gene expressions, cell invasions, and wound healing rates in the Model and Blank groups were significantly suppressed compared with that of NC group (P<0.001, all). With VIM-AS1 supplementation, VIM-AS1 gene expression, cell invasion, and wound healing rate in the VIM-AS1 group were significantly increased compared with that in the Model group (P<0.001). RT-PCR and WB assay showed that E-cadherin gene and protein expressions in Model and Blank groups were significantly upregulated compared with the NC group (P<0.001); Snail and Vimentin gene and protein expressions in the Model and Blank groups were significantly downregulated compared with the NC group (P<0.001). With VIM-AS1 supplementation, E-cadherin, Snail, and Vimentin gene and proteins expression levels in the VIM-AS1 group were significantly different compared with that in the Model group (P<0.001). CONCLUSIONS VIM-AS1 promotes preeclampsia via inducing epithelial-to-mesenchymal transition (EMT).

Citing Articles

Integrated analysis of DNA methylation and transcriptome profiles to identify oxidative stress-related placenta-specific molecules for preeclampsia.

Xu Y, Zeng X, Guo S, Liao Y, Zhao D J Obstet Gynaecol Res. 2025; 51(3):e16209.

PMID: 40048749 PMC: 11884871. DOI: 10.1111/jog.16209.


VIM-AS1, which is regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma.

Han S, Ko J, Jung S, Oh S, Kim D, Kang E Exp Mol Med. 2024; 56(12):2617-2630.

PMID: 39617786 PMC: 11671536. DOI: 10.1038/s12276-024-01352-6.


lncRNA VIM-AS1 acts as a prognostic biomarker and promotes apoptosis in lung adenocarcinoma.

Kang J, Abudurufu M, Zhang S, Jiang W, Luo H J Cancer. 2023; 14(8):1417-1426.

PMID: 37283796 PMC: 10240666. DOI: 10.7150/jca.83639.


Melatonin Alleviates Oxidative Stress Induced by HO in Porcine Trophectoderm Cells.

Fu Y, Chen Y, Jin Z, Gao H, Song G, Wang Q Antioxidants (Basel). 2022; 11(6).

PMID: 35739944 PMC: 9219737. DOI: 10.3390/antiox11061047.


Roles of noncoding RNAs in preeclampsia.

Sun N, Qin S, Zhang L, Liu S Reprod Biol Endocrinol. 2021; 19(1):100.

PMID: 34215266 PMC: 8252232. DOI: 10.1186/s12958-021-00783-4.


References
1.
Goldenberg R, McClure E, Belizan J . Translating research evidence into practice: a report from the 2 International Conference on Maternal and Newborn Health from KLE University - Belagavi, India. Reprod Health. 2018; 15(Suppl 1):99. PMC: 6019996. DOI: 10.1186/s12978-018-0523-6. View

2.
Zhou Y, Yuge A, Rajah A, Unek G, Rinaudo P, Maltepe E . LIMK1 regulates human trophoblast invasion/differentiation and is down-regulated in preeclampsia. Am J Pathol. 2014; 184(12):3321-31. PMC: 4258498. DOI: 10.1016/j.ajpath.2014.08.013. View

3.
Davis E, Lazdam M, Lewandowski A, Worton S, Kelly B, Kenworthy Y . Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012; 129(6):e1552-61. DOI: 10.1542/peds.2011-3093. View

4.
Seely E, Rich-Edwards J, Lui J, Nicklas J, Saxena A, Tsigas E . Risk of future cardiovascular disease in women with prior preeclampsia: a focus group study. BMC Pregnancy Childbirth. 2013; 13:240. PMC: 3878371. DOI: 10.1186/1471-2393-13-240. View

5.
Lawlor D, Macdonald-Wallis C, Fraser A, Nelson S, Hingorani A, Davey Smith G . Cardiovascular biomarkers and vascular function during childhood in the offspring of mothers with hypertensive disorders of pregnancy: findings from the Avon Longitudinal Study of Parents and Children. Eur Heart J. 2011; 33(3):335-45. PMC: 3270043. DOI: 10.1093/eurheartj/ehr300. View